CIDRAP newsletters options
Essential workers include first responders, teachers, public transit employees, and grocery store staff.
The company says it began a trial among adolescents; results are expected in 2021.
The US becomes the first nation to have 2 authorized COVID-19 vaccines with clear, compelling efficacy data.
COVID activity remains intense in Europe, and South Africa is probing a new SARS-CoV-2 variant.
Vaccine distribution to states is hitting some unexpected snags, as the surge ahead of Christmas accelerates, putting record numbers of Americans in the hospital.
Though the studies don't settle questions about the 2 antibody treatments, they shed light on potential clinical benefits.
Five countries across Asia and Africa report new circulating vaccine-derived poliovirus type 2 (cVDPV2), according to Global Polio Eradication Initiative's weekly report.
A Latin American study of children with COVID-19–related multisystem inflammatory syndrome (MIS-C) in The Pediatric Infectious Disease Journal found higher rates of the disease among Latin/Hispanic children compared with other global estimates.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
England's National Health Service (NHS) announced today that it has selected the first antibiotics to be purchased through the United Kingdom's subscription-style payment model.
US officials report new single-day highs in cases (247,403), hospitalizations (113,090), and deaths (3,656).
An HHS official says the US may ship 7.9 million doses to states next week if the Moderna vaccine is approved, including 5.9 million doses of Moderna's vaccine.
In just 6 months the virus killed an estimated 173,000 people, and in 5 months about 4,500 young adults.
Only 62.4% of 16-month-old US children received the MMR vaccine from June to August, down from 72.0% before the pandemic.
The European Commission this week published its latest annual progress report on implementation of the European One Health Action Plan against Antimicrobial Resistance (AMR).
A study published today in the Centers for Disease Control and Prevention's (CDC's) Morbidity and Mortality Weekly Report (MMWR) highlights factors that may increase the risk of infection with SARS-CoV-2, the virus that causes COVID-19, among US poultry facility workers—especially those who are foreign-born.
Experts estimate that nearly a fourth of the world's people may not have access to a vaccine till at least 2022.
Sales of medically important antibiotics for food animals rise 3% from 2018 to 2019, following a 9% increase the year before.
COVID-19 patients had 4 times the risk of mechanical ventilation and double the risk of ICU care.
COVID-19 cases, hospitalizations, and deaths in the US continue to climb.
About 2 in 10 US school districts have said they will continue, or are considering continuing, distance learning after the COVID-19 pandemic ends, citing student and parent demand, according to a Rand Corporation study released yesterday.
